Elsevier

Vaccine

Volume 34, Issue 26, 3 June 2016, Pages 2953-2958
Vaccine

Status of research and development of vaccines for Streptococcus pyogenes

https://doi.org/10.1016/j.vaccine.2016.03.073Get rights and content
Under a Creative Commons license
open access

Highlights

  • There is a clear case for development of vaccines against S. pyogenes given the large disease burden.

  • The biological feasibility of vaccines against S. pyogenes is well supported.

  • There are multiple vaccine candidates in clinical and pre-clinical development.

Abstract

Streptococcus pyogenes is an important global pathogen, causing considerable morbidity and mortality, especially in low and middle income countries where rheumatic heart disease and invasive infections are common. There is a number of promising vaccine candidates, most notably those based on the M protein, the key virulence factor for the bacterium. Vaccines against Streptococcus pyogenes are considered as impeded vaccines because of a number of crucial barriers to development. Considerable effort is needed by key players to bring current vaccine candidates through phase III clinical trials and there is a clear need to develop a roadmap for future development of current and new candidates.

Keywords

Streptococcus pyogenes
Group A Streptococcus
Vaccine
Rheumatic fever

Cited by (0)